Ignite Creation Date:
2024-05-06 @ 3:06 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04510818
Status:
UNKNOWN
Last Update Posted:
2020-08-14
First Post:
2020-08-10
Brief Title:
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial Cohort 2
Sponsor:
Organization:
Ruijin Hospital